Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biomarkers
Pharma
ASCO: Lilly tees up expansion into Retevmo’s 'final chapter’
Retevmo showed an 83% reduction in disease progression or death when used as an adjuvant therapy in early-stage RET fusion-positive lung cancer.
Zoey Becker
May 31, 2026 8:00am
Guardant backs ALA's lung cancer testing awareness drive
Sep 25, 2025 9:45am
Genentech takes to TikTok to push biomarker testing message
Aug 2, 2024 7:15am
American Lung Association aims to ‘BEAT’ cancer in new campaign
Jul 16, 2024 1:46pm
Evidence pushes back on FDA's use of surrogate markers: report
May 29, 2024 11:25am
Golf pro Day hosts AZ video series to push biomarker testing
Apr 15, 2022 7:48am
